Dalbavancin in Real Clinical Practice in Spain

Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections

NCT01339091 ·Status: COMPLETED ·Phase: PHASE3

Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA

NCT02814916 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Dalbavancin As Suppressive Therapy

NCT06899906 ·Status: RECRUITING

Study Of Dalbavancin Drug Levels Achieved In Hospitalized Adolescents Who Are Receiving Antibiotic Therapy For Bacterial Infections

NCT00678106 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy Study of CUBICIN (Daptomycin) Under Conditions of Actual Use

NCT01219114 ·Status: WITHDRAWN

Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Patients With Osteomyelitis

NCT03091439 ·Status: TERMINATED ·Phase: PHASE2

Evaluation of the Efficacy and Safety of Suppressive Therapy With DALBAVANCINE in Device Infections

NCT06089044 ·Status: COMPLETED

Development of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

NCT03233438 ·Status: COMPLETED ·Phase: PHASE4

A Single Dose Study To Investigate The Pharmacokinetics and Safety Of Dalbavancin In Hospitalized Children Aged 3 Months to 11 Years.

NCT01946568 ·Status: COMPLETED ·Phase: PHASE1

Study on the Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Participants With Osteomyelitis

NCT02685033 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial Infection

NCT02688790 ·Status: TERMINATED ·Phase: PHASE1

Dalbavancin Outpatient Pilot

NCT03982030 ·Status: WITHDRAWN ·Phase: PHASE4

Safety and Efficacy of Dalbavancin Versus Vancomycin in the Treatment of Catheter-Related Bloodstream Infections

NCT00057369 ·Status: UNKNOWN ·Phase: PHASE2

Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

NCT01119105 ·Status: COMPLETED ·Phase: PHASE2

Pilot Study of the Safety and Clinical Efficacy of Topical Dermacyn™ Wound Care to Treat Mild Diabetic Foot Infections

NCT00516958 ·Status: COMPLETED ·Phase: PHASE2

DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia

NCT04775953 ·Status: COMPLETED ·Phase: PHASE2

Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia

NCT03138733 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure Infections

NCT00711802 ·Status: COMPLETED ·Phase: PHASE4

Study to Compare Efficacy and Safety of Daptomycin in Elderly Patients With Complicated Skin and Soft Tissue Infections

NCT01184872 ·Status: COMPLETED ·Phase: PHASE3

Ceftobiprole in the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections

NCT03137173 ·Status: COMPLETED ·Phase: PHASE3

Daptomycin in the Treatment of Patients With Renal Insufficiency and Complicated Skin and Skin Structure Infections

NCT00102947 ·Status: TERMINATED ·Phase: PHASE4

Dalbavancin Versus Standard Antibiotic Therapy for Catheter-related Bloodstream Infections Due to Staphylococcus Aureus

NCT05117398 ·Status: RECRUITING ·Phase: PHASE3

Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections

NCT00210899 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections

NCT00430937 ·Status: TERMINATED ·Phase: PHASE3

Intravenous Colistin Versus Intravenous Colistin Plus Nebulized Colistin in VAP Due MDR Acinetobacter Baumannii

NCT00645723 ·Status: UNKNOWN ·Phase: PHASE3